Cargando…

Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines

The antigens for acellular pertussis vaccines are made up of protein components that are purified directly from Bordetella pertussis (B. pertussis) bacterial fermentation. As such, there are additional B. pertussis toxins that must be monitored as residuals during process optimization. This paper de...

Descripción completa

Detalles Bibliográficos
Autores principales: Szymkowicz, Lisa, Gerard, Jeffery, Messham, Benjamin, Tam, Wai Wan Vivian, James, D. Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624556/
https://www.ncbi.nlm.nih.gov/pubmed/34822547
http://dx.doi.org/10.3390/toxins13110763
_version_ 1784606203469365248
author Szymkowicz, Lisa
Gerard, Jeffery
Messham, Benjamin
Tam, Wai Wan Vivian
James, D. Andrew
author_facet Szymkowicz, Lisa
Gerard, Jeffery
Messham, Benjamin
Tam, Wai Wan Vivian
James, D. Andrew
author_sort Szymkowicz, Lisa
collection PubMed
description The antigens for acellular pertussis vaccines are made up of protein components that are purified directly from Bordetella pertussis (B. pertussis) bacterial fermentation. As such, there are additional B. pertussis toxins that must be monitored as residuals during process optimization. This paper describes a liquid chromatography mass spectrometry (LC-MS) method for simultaneous analysis of residual protein toxins adenylate cyclase toxin (ACT) and dermonecrotic toxin (DNT), as well as a small molecule glycopeptide, tracheal cytotoxin (TCT) in a Pertussis toxin vaccine antigen. A targeted LC-MS technique called multiple reaction monitoring (MRM) is used for quantitation of ACT and TCT, which have established limits in drug product formulations. However, DNT is currently monitored in an animal test, which does not have an established quantitative threshold. New approaches for DNT testing are discussed, including a novel standard based on concatenated quantitation sequences for ACT and DNT. Collectively, the method represents a “3-in-1” analytical simplification for monitoring process-related residuals during development of B. pertussis vaccines.
format Online
Article
Text
id pubmed-8624556
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86245562021-11-27 Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines Szymkowicz, Lisa Gerard, Jeffery Messham, Benjamin Tam, Wai Wan Vivian James, D. Andrew Toxins (Basel) Article The antigens for acellular pertussis vaccines are made up of protein components that are purified directly from Bordetella pertussis (B. pertussis) bacterial fermentation. As such, there are additional B. pertussis toxins that must be monitored as residuals during process optimization. This paper describes a liquid chromatography mass spectrometry (LC-MS) method for simultaneous analysis of residual protein toxins adenylate cyclase toxin (ACT) and dermonecrotic toxin (DNT), as well as a small molecule glycopeptide, tracheal cytotoxin (TCT) in a Pertussis toxin vaccine antigen. A targeted LC-MS technique called multiple reaction monitoring (MRM) is used for quantitation of ACT and TCT, which have established limits in drug product formulations. However, DNT is currently monitored in an animal test, which does not have an established quantitative threshold. New approaches for DNT testing are discussed, including a novel standard based on concatenated quantitation sequences for ACT and DNT. Collectively, the method represents a “3-in-1” analytical simplification for monitoring process-related residuals during development of B. pertussis vaccines. MDPI 2021-10-28 /pmc/articles/PMC8624556/ /pubmed/34822547 http://dx.doi.org/10.3390/toxins13110763 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Szymkowicz, Lisa
Gerard, Jeffery
Messham, Benjamin
Tam, Wai Wan Vivian
James, D. Andrew
Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines
title Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines
title_full Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines
title_fullStr Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines
title_full_unstemmed Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines
title_short Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines
title_sort design of a quantitative lc-ms method for residual toxins adenylate cyclase toxin (act), dermonecrotic toxin (dnt) and tracheal cytotoxin (tct) in bordetella pertussis vaccines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624556/
https://www.ncbi.nlm.nih.gov/pubmed/34822547
http://dx.doi.org/10.3390/toxins13110763
work_keys_str_mv AT szymkowiczlisa designofaquantitativelcmsmethodforresidualtoxinsadenylatecyclasetoxinactdermonecrotictoxindntandtrachealcytotoxintctinbordetellapertussisvaccines
AT gerardjeffery designofaquantitativelcmsmethodforresidualtoxinsadenylatecyclasetoxinactdermonecrotictoxindntandtrachealcytotoxintctinbordetellapertussisvaccines
AT messhambenjamin designofaquantitativelcmsmethodforresidualtoxinsadenylatecyclasetoxinactdermonecrotictoxindntandtrachealcytotoxintctinbordetellapertussisvaccines
AT tamwaiwanvivian designofaquantitativelcmsmethodforresidualtoxinsadenylatecyclasetoxinactdermonecrotictoxindntandtrachealcytotoxintctinbordetellapertussisvaccines
AT jamesdandrew designofaquantitativelcmsmethodforresidualtoxinsadenylatecyclasetoxinactdermonecrotictoxindntandtrachealcytotoxintctinbordetellapertussisvaccines